Salt River Medical Group Weight Loss

Overview

Semaglutide and tirzepatide are both injectable medications that can support weight management by helping regulate appetite and food intake. Semaglutide works primarily by activating the GLP-1 receptor, which can increase feelings of fullness, reduce hunger, and slow stomach emptying. Tirzepatide takes a dual approach by activating both GLP-1 and GIP receptors. This combination may influence appetite regulation and energy balance through multiple pathways, potentially providing greater reductions in body weight for some patients compared with GLP-1 receptor activation alone. Clinical studies have shown that both medications can produce meaningful weight loss when combined with healthy nutrition and physical activity, with tirzepatide generally demonstrating greater average weight reductions in head-to-head research. However, individual responses vary, and the most appropriate medication depends on factors such as treatment goals, tolerability, medical history, and guidance from a healthcare professional. Ultimately, the goal is not simply choosing the medication associated with the greatest average weight loss, but finding an effective and sustainable treatment approach that fits the individual patient.

Treatments / Services Offered

Map

Practice notes

FAQs